| Code | 34010 | ||||||||||
| MA number | 44/0356/00-S | ||||||||||
| Product Form: | sol inj 1x25 ml/50 mg (liek.PP - povolenie uvádzať na trh končí dňa 31.07.2024) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 31.10.2000 |
| PIL: |
PIL_FARMORUBICIN PFS_05.2022.pdf
|
| SPC: |
SPC_FARMORUBICIN PFS_05.2023.pdf
|
| Safety feature | Yes |
| Data update: | 30.04.2024 |
